Skip to main content

Investor RelationsWealth Management:  CA  |  UK  |  AU

Menu

BEIJING | CHINA

Partnering to deliver
global solutions
tailored to your unique needs

Transactions

Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 187 transactions and raising C$19.5 Billion on behalf of our clients in Q3/20211.2.

Filter our transactions* using the categories below:

Mercer Park Brand Acquisition Corp.
June 2021

Mercer Park Brand Acquisition Corp.

Financial Advisor
CANNABIS M&A ADVISORY HEALTHCARE SPACS US
View transaction detail
Trulieve
US$2.1b
May 2021

Trulieve

Financial Advisor to Trulieve on its acquisition of Harvest Health & Recreation Inc.
CANNABIS HEALTHCARE M&A ADVISORY CANADA
Ascend Wellness Holdings
US$29m
May 2021

Ascend Wellness Holdings

Sole Lead Bookrunner (IPO)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS US
FlowerOne
$140m
April 2021

FlowerOne

Financial advisor (restructuring)
CANNABIS HEALTHCARE DEBT ADVISORY & RESTRUCTURING US
Trulieve
C$288m
April 2021

Trulieve

Sole Lead Bookrunner (Equity Financing)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS CANADA
Driven By Stem
C$10m
April 2021

Driven By Stem

Sole Lead Bookrunner (Equity Financing)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS CANADA
Greenlane
C$211m
March 2021

Greenlane

Financial Advisor to Greenlane on its merger with KushCo Holdings
CANNABIS HEALTHCARE M&A ADVISORY US CANADA
WeedMD
C$17m
March 2021

WeedMD

Co-Lead Bookrunner (Equity Financing)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS CANADA
Verano Holdings
C$100m
March 2021

Verano Holdings

Co-Lead Bookrunner (Equity Financing)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS CANADA
Emmac Life Sciences PLC
C$491m
March 2021

Emmac Life Sciences PLC

Financial Advisor to Emmac Life Sciences PLC on its sale to Curaleaf
CANNABIS HEALTHCARE M&A ADVISORY UK CANADA
1933 Industries Inc.
C$5m
March 2021

1933 Industries Inc.

Sole Lead Bookrunner (Equity Financing)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS CANADA
Tetra Bio Pharma
C$14m
March 2021

Tetra Bio Pharma

Co-Lead Bookrunner (Equity Financing)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS CANADA